- Awards & Rankings
- France's attractiveness
- Research & Innovation
The Prix Galien Medstartup fosters transatlantic, private-public sector collaborations and promotes innovative research partnerships among major integrated pharmaceutical companies, biotech firms, and medical device manufacturers, including e-health vendors.
This unique initiative, which takes place in the same venue and at the same time as the Galien Forum, was built on several years of cooperation between the Galien Foundation and Business France with three core goals: Strengthen commercial partnerships that bridge the traditional silos between government, industry and academia; Support large groups in their transformation; Promote cross-border trade, jobs, and economic growth.
Companies can submit their application in 3 categories:
- Medtech/Digital Health
- Underserved Populations
To be eligible for the Prix Galien Medstartup, 3 main criteria must be met:
- Have an innovative product in line with the American market
- Generate a revenue over € 500K, otherwise have raised funds in seed, series A or more
- Present a collaboration with a North American partner: academic, hospital, investor or industrial.
The winners will be announced during the Galien Week of Innovation, on October 28th 2021. The same day, they will also meet with major pharmaceutical, biotech and medtech companies, insurances, patient associations, as well as investors on the Galien Medstartup Partnering platform to discuss development of new partnerships.
Years of existence
Projects of collaboration signed
Millions $ fund raised since the first edition in 2013